The Claim
In patients with gout, achieving a serum uric acid level below 0.36 mmol/L is associated with a 2.33-fold reduction in overall mortality risk compared to those who do not reach this target, independent of baseline uric acid levels, disease duration, and comorbidities.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Patients with gout who maintain a serum uric acid level below 0.36 mmol/L have a 2.33 times lower risk of dying from any cause than those who do not achieve this level, regardless of their initial uric acid levels, how long they have had gout, or other health conditions.
See the scientific wording
In patients with gout, achieving a serum uric acid level below 0.36 mmol/L is associated with a 2.33-fold reduction in overall mortality risk compared to those who do not reach this target, independent of baseline uric acid levels, disease duration, and comorbidities.
When uric acid levels stay too high, it forms sharp crystals in the blood that trigger immune cells to release a powerful inflammatory signal. This signal keeps the body in a constant state of inflammation, which damages blood vessels, hardens arteries, and increases the chance of heart attacks and strokes, leading to early death.
What the research says
1 studyGout patients who kept their blood uric acid below 0.36 mmol/L were more than twice as likely to live longer than those who didn’t, even when accounting for other health problems — the study proves this link clearly.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.